Cargando…

The Long and the Short of Missing Medicines

Who would have thought that in the most recent decade of the 21st century, shortages of medicines would be on the rise? As the authors will show, it is not simply about price, but involves other factors such as sudden outbreaks of a disease or diseases, a lack of raw materials, manufacturing issues...

Descripción completa

Detalles Bibliográficos
Autores principales: Horgan, Denis, Doeswijk, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945889/
https://www.ncbi.nlm.nih.gov/pubmed/31988933
http://dx.doi.org/10.1159/000481565
_version_ 1783485253469339648
author Horgan, Denis
Doeswijk, Robin
author_facet Horgan, Denis
Doeswijk, Robin
author_sort Horgan, Denis
collection PubMed
description Who would have thought that in the most recent decade of the 21st century, shortages of medicines would be on the rise? As the authors will show, it is not simply about price, but involves other factors such as sudden outbreaks of a disease or diseases, a lack of raw materials, manufacturing issues and high demand. Shortages of medicines can lead to higher costs and lower quality and safety of care, while unavailable medicines tend to be substituted with often less effective medicines, which can even be more costly. Possible solutions involve a monitoring of supply chains and “early warning” systems as well as Member States getting together to purchase medicines as a group. There is no single answer, and there is much work to be done.
format Online
Article
Text
id pubmed-6945889
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-69458892020-01-27 The Long and the Short of Missing Medicines Horgan, Denis Doeswijk, Robin Biomed Hub Commentary Who would have thought that in the most recent decade of the 21st century, shortages of medicines would be on the rise? As the authors will show, it is not simply about price, but involves other factors such as sudden outbreaks of a disease or diseases, a lack of raw materials, manufacturing issues and high demand. Shortages of medicines can lead to higher costs and lower quality and safety of care, while unavailable medicines tend to be substituted with often less effective medicines, which can even be more costly. Possible solutions involve a monitoring of supply chains and “early warning” systems as well as Member States getting together to purchase medicines as a group. There is no single answer, and there is much work to be done. S. Karger AG 2017-11-21 /pmc/articles/PMC6945889/ /pubmed/31988933 http://dx.doi.org/10.1159/000481565 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Commentary
Horgan, Denis
Doeswijk, Robin
The Long and the Short of Missing Medicines
title The Long and the Short of Missing Medicines
title_full The Long and the Short of Missing Medicines
title_fullStr The Long and the Short of Missing Medicines
title_full_unstemmed The Long and the Short of Missing Medicines
title_short The Long and the Short of Missing Medicines
title_sort long and the short of missing medicines
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945889/
https://www.ncbi.nlm.nih.gov/pubmed/31988933
http://dx.doi.org/10.1159/000481565
work_keys_str_mv AT horgandenis thelongandtheshortofmissingmedicines
AT doeswijkrobin thelongandtheshortofmissingmedicines
AT horgandenis longandtheshortofmissingmedicines
AT doeswijkrobin longandtheshortofmissingmedicines